Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editorial: Insights in head and neck cancer: 2021.
Lybaert W, Vermorken JB. Lybaert W, et al. Among authors: vermorken jb. Front Oncol. 2023 Mar 28;13:1180965. doi: 10.3389/fonc.2023.1180965. eCollection 2023. Front Oncol. 2023. PMID: 37056347 Free PMC article. No abstract available.
Editorial: Head and neck cancer in the elderly.
Szturz P, Vermorken JB. Szturz P, et al. Among authors: vermorken jb. Front Oncol. 2023 Jun 22;13:1218274. doi: 10.3389/fonc.2023.1218274. eCollection 2023. Front Oncol. 2023. PMID: 37427107 Free PMC article. No abstract available.
Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses.
Limkin E, Blanchard P, Lacas B, Bourhis J, Parmar M, Licitra L, Le QT, Yom SS, Fortpied C, Langendijk J, Vermorken JB, Bernier J, Overgaard J, Harris J, Pignon JP, Auperin A; MACH-NC* and MARCH** collaborative groups. Limkin E, et al. Among authors: vermorken jb. Radiother Oncol. 2024 Jan;190:110011. doi: 10.1016/j.radonc.2023.110011. Epub 2023 Nov 11. Radiother Oncol. 2024. PMID: 37956890
Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity.
Zaryouh H, De Pauw I, Baysal H, Melis J, Van den Bossche V, Hermans C, Lau HW, Lambrechts H, Merlin C, Corbet C, Peeters M, Vermorken JB, De Waele J, Lardon F, Wouters A. Zaryouh H, et al. Among authors: vermorken jb. Cancer Drug Resist. 2023 Oct 17;6(4):709-728. doi: 10.20517/cdr.2023.62. eCollection 2023. Cancer Drug Resist. 2023. PMID: 38239393 Free PMC article.
Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer.
Saba NF, Pamulapati S, Patel B, Mody M, Strojan P, Takes R, Mäkitie AA, Cohen O, Pace-Asciak P, Vermorken JB, Bradford C, Forastiere A, Teng Y, Wieland A, Ferlito A. Saba NF, et al. Among authors: vermorken jb. Cancers (Basel). 2023 Mar 24;15(7):1959. doi: 10.3390/cancers15071959. Cancers (Basel). 2023. PMID: 37046621 Free PMC article. Review.
Estimating the Prevalence of a True Oligometastatic Disease.
Szturz P, Bonomo P, Vermorken JB. Szturz P, et al. Among authors: vermorken jb. Cancers (Basel). 2022 Dec 30;15(1):214. doi: 10.3390/cancers15010214. Cancers (Basel). 2022. PMID: 36612215 Free PMC article.
The prognostic impact of the immune signature in head and neck squamous cell carcinoma.
Baysal H, Siozopoulou V, Zaryouh H, Hermans C, Lau HW, Lambrechts H, Fransen E, De Pauw I, Jacobs J, Peeters M, Pauwels P, Vermorken JB, Smits E, Lardon F, De Waele J, Wouters A. Baysal H, et al. Among authors: vermorken jb. Front Immunol. 2022 Oct 4;13:1001161. doi: 10.3389/fimmu.2022.1001161. eCollection 2022. Front Immunol. 2022. PMID: 36268020 Free PMC article.
Prognostic implications of cellular senescence in resected non-small cell lung cancer.
Domen A, Deben C, De Pauw I, Hermans C, Lambrechts H, Verswyvel J, Siozopoulou V, Pauwels P, Demaria M, van de Wiel M, Janssens A, Hendriks JMH, Van Schil P, Vermorken JB, Vandamme T, Prenen H, Peeters M, Lardon F, Wouters A. Domen A, et al. Among authors: vermorken jb. Transl Lung Cancer Res. 2022 Aug;11(8):1526-1539. doi: 10.21037/tlcr-22-192. Transl Lung Cancer Res. 2022. PMID: 36090630 Free PMC article.
524 results